Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

E-Cigs and Smoking

Studies Seeking Participants Icon Studies Seeking Participants Location icon Residents of North Carolina 18-55 Ages 18-55 Gender Icon All Genders
cigarettes and an electronic cigarette device
  1. Home
  2. Studies
  3. E-Cigs and Smoking
  4. Study Overview

We protect our registrants' privacy

If you are a man or woman, 18-55 years old, living in the Raleigh-Durham-Chapel Hill area, and smoke cigarettes or use an electronic nicotine delivery system (e-cigarette), please join an important study on smokers being conducted by the National Institute of Environmental Health Sciences (NIEHS).

Who Can Participate?

  • Healthy men and women aged 18-55
  • Current cigarette smokers or users of nicotine-containing e-cigarettes (can be using both) 

The definition of healthy for this study means that you feel well and can perform normal activities. If you have a chronic condition, such as high blood pressure, healthy can also mean that you are being treated and the condition is under control.

What Is Required?

  • One visit to donate blood, urine, and saliva samples
  • Volunteers will be compensated up to $60

Who Is Running the Study?

The study is run by physicians at the  National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, U.S. Department of Health and Human Services.

Lead Researcher

Stavros Garantziotis, M.D.

Stavros Garantziotis, M.D. is passionate about finding cures for chronic lung disease like asthma, COPD and pulmonary fibrosis. He believes that if we can understand the mechanism of disease development for every individual patient, we can design intelligent and effective treatment with less side effects. Dr. Garantziotis obtained his medical degree at the Albert-Ludwigs-University in Germany. He trained in Internal Medicine at the Albert Einstein College of Medicine in New York and in Pulmonary and Critical Care Medicine at Duke University Medical Center, where he was a faculty member before joining the NIEHS to direct the Clinical Research Unit.

Research Webpage

For More Information About This Study

This content is available to use on your website.

Please visit NIEHS Syndication to get started.